Skip to content
Recall Observatory FDA recall evidence

Device product

ADVIA Centaur SARS-CoV-2 Antigen Assay (100 Test Kit), SMN # 11207866

Z-0196-2022

September 22, 2021

Class II

Product summary

Firm
Siemens Healthcare Diagnostics, Inc
Event
Event 88768
Status
Terminated
Classification
Class II
Quantity
261 kits
Official record key
device-enforcement:Z-0196-2022

Official wording

Reason: Data provided in the Emergency Use Authorization (EUA) submission was insufficient to determine that the assays were adequately validated for the intended use.

Code information: Lot # 44990001, Exp. Date 2021-10-07, UDI # (01)00630414611747(10)44990001(17)20211007. Lot # 60408003, Exp. Date 2021-11-12, UDI # (01)00630414611747(10)60408003(17)20211112.

Distribution pattern: US Nationwide distribution in the states of AK, CA, CO, DC, GA, IL, ME, NC, NV, NY, OR, PA, PR, VA and VI.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Data provided in the Emergency Use Authorization (EUA) submission was insufficient to determine that the assays were adequately validated for the intended use.

Field note

Send feedback

We'll only use this to respond to your feedback.